GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » New Journey Health Technology Group Co Ltd (SZSE:002219) » Definitions » ROE %

New Journey Health Technology Group Co (SZSE:002219) ROE % : 4.39% (As of Mar. 2024)


View and export this data going back to 2008. Start your Free Trial

What is New Journey Health Technology Group Co ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. New Journey Health Technology Group Co's annualized net income for the quarter that ended in Mar. 2024 was ¥98 Mil. New Journey Health Technology Group Co's average Total Stockholders Equity over the quarter that ended in Mar. 2024 was ¥2,222 Mil. Therefore, New Journey Health Technology Group Co's annualized ROE % for the quarter that ended in Mar. 2024 was 4.39%.

The historical rank and industry rank for New Journey Health Technology Group Co's ROE % or its related term are showing as below:

SZSE:002219' s ROE % Range Over the Past 10 Years
Min: -173.41   Med: 3.24   Max: 28.21
Current: 1.57

During the past 13 years, New Journey Health Technology Group Co's highest ROE % was 28.21%. The lowest was -173.41%. And the median was 3.24%.

SZSE:002219's ROE % is ranked worse than
57.23% of 996 companies
in the Drug Manufacturers industry
Industry Median: 4.225 vs SZSE:002219: 1.57

New Journey Health Technology Group Co ROE % Historical Data

The historical data trend for New Journey Health Technology Group Co's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

New Journey Health Technology Group Co ROE % Chart

New Journey Health Technology Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -173.41 -31.79 -44.04 9.53 1.57

New Journey Health Technology Group Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.67 6.88 -4.48 -0.49 4.39

Competitive Comparison of New Journey Health Technology Group Co's ROE %

For the Drug Manufacturers - Specialty & Generic subindustry, New Journey Health Technology Group Co's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


New Journey Health Technology Group Co's ROE % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, New Journey Health Technology Group Co's ROE % distribution charts can be found below:

* The bar in red indicates where New Journey Health Technology Group Co's ROE % falls into.



New Journey Health Technology Group Co ROE % Calculation

New Journey Health Technology Group Co's annualized ROE % for the fiscal year that ended in Dec. 2023 is calculated as

ROE %=Net Income (A: Dec. 2023 )/( (Total Stockholders Equity (A: Dec. 2022 )+Total Stockholders Equity (A: Dec. 2023 ))/ count )
=30.777/( (1723.169+2195.689)/ 2 )
=30.777/1959.429
=1.57 %

New Journey Health Technology Group Co's annualized ROE % for the quarter that ended in Mar. 2024 is calculated as

ROE %=Net Income (Q: Mar. 2024 )/( (Total Stockholders Equity (Q: Dec. 2023 )+Total Stockholders Equity (Q: Mar. 2024 ))/ count )
=97.62/( (2195.689+2247.358)/ 2 )
=97.62/2221.5235
=4.39 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Mar. 2024) net income data. ROE % is displayed in the 30-year financial page.


New Journey Health Technology Group Co  (SZSE:002219) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Mar. 2024 )
=Net Income/Total Stockholders Equity
=97.62/2221.5235
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(97.62 / 3451.352)*(3451.352 / 6134.2365)*(6134.2365 / 2221.5235)
=Net Margin %*Asset Turnover*Equity Multiplier
=2.83 %*0.5626*2.7613
=ROA %*Equity Multiplier
=1.59 %*2.7613
=4.39 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Mar. 2024 )
=Net Income/Total Stockholders Equity
=97.62/2221.5235
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (97.62 / 112.668) * (112.668 / 291.048) * (291.048 / 3451.352) * (3451.352 / 6134.2365) * (6134.2365 / 2221.5235)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.8664 * 0.3871 * 8.43 % * 0.5626 * 2.7613
=4.39 %

Note: The net income data used here is four times the quarterly (Mar. 2024) net income data. The Revenue data used here is four times the quarterly (Mar. 2024) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


New Journey Health Technology Group Co ROE % Related Terms

Thank you for viewing the detailed overview of New Journey Health Technology Group Co's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


New Journey Health Technology Group Co (SZSE:002219) Business Description

Traded in Other Exchanges
N/A
Address
Duyiyi Industrial Park, Wangba, Kang County, Gansu Province, Longnan, CHN, 610000
New Journey Health Technology Group Co Ltd formerly Hengkang Medical Group Co Ltd is engaged in research, development, and manufacturing of natural herbal medicines. The company's products include analgesic and haemostatic drugs.
Executives
Song Li Hua Directors, executives
Yu Mei Directors, executives
Wang Yong Executives
Zuo Bin Lin Executives
Tang Can Director
Duan Zhi Ping Director
Zhou Xian Min Director
Guo Kai Executives
Xie Hai Executives
Shi Xiao Ming Executives
Li Yu Fei Supervisors
Huang Rui Directors, executives
Pan Yu Supervisors
Liao Li Dong Executives

New Journey Health Technology Group Co (SZSE:002219) Headlines

No Headlines